LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 13 of 497
Next
>>
>
301 to 325 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	TGX221	0.04	uM	LJP5	1	H24	72	hr	1097	3732	3769	0.9900	0.9860
BT-20	TGX221	0.04	uM	LJP5	2	H24	72	hr	1097	3583	3769	0.9505	0.9302
BT-20	TGX221	0.04	uM	LJP5	3	H24	72	hr	1097	3742	3769	0.9927	0.9897
BT-20	Torin1	0.04	uM	LJP6	1	O18	72	hr	1097	1487	3769	0.3945	0.1459
BT-20	Torin1	0.04	uM	LJP6	2	O18	72	hr	1097	1501	3769	0.3982	0.1511
BT-20	Torin1	0.04	uM	LJP6	3	O18	72	hr	1097	1555	3769	0.4125	0.1713
BT-20	Torin2	0.04	uM	LJP5	1	I24	72	hr	1097	996	3769	0.2642	-0.0379
BT-20	Torin2	0.04	uM	LJP5	2	I24	72	hr	1097	934	3769	0.2478	-0.0611
BT-20	Torin2	0.04	uM	LJP5	3	I24	72	hr	1097	977	3769	0.2592	-0.0450
BT-20	Tozasertib	0.04	uM	LJP5	1	B18	72	hr	1097	1813	3769	0.4810	0.2678
BT-20	Tozasertib	0.04	uM	LJP5	2	B18	72	hr	1097	1992	3769	0.5285	0.3348
BT-20	Tozasertib	0.04	uM	LJP5	3	B18	72	hr	1097	2278	3769	0.6043	0.4419
BT-20	Trametinib	0.04	uM	LJP5	1	P24	72	hr	1097	2687	3769	0.7128	0.5949
BT-20	Trametinib	0.04	uM	LJP5	2	P24	72	hr	1097	3198	3769	0.8484	0.7861
BT-20	Trametinib	0.04	uM	LJP5	3	P24	72	hr	1097	3250	3769	0.8622	0.8056
BT-20	TWS119	0.04	uM	LJP5	1	M06	72	hr	1097	3697	3769	0.9808	0.9729
BT-20	TWS119	0.04	uM	LJP5	2	M06	72	hr	1097	3995	3769	1.0598	1.0844
BT-20	TWS119	0.04	uM	LJP5	3	M06	72	hr	1097	3893	3769	1.0328	1.0462
BT-20	Vemurafenib	0.04	uM	LJP5	1	C18	72	hr	1097	3746	3769	0.9938	0.9912
BT-20	Vemurafenib	0.04	uM	LJP5	2	C18	72	hr	1097	3479	3769	0.9229	0.8913
BT-20	Vemurafenib	0.04	uM	LJP5	3	C18	72	hr	1097	3814	3769	1.0118	1.0166
BT-20	Withaferin A	0.04	uM	LJP5	1	G18	72	hr	1097	4047	3769	1.0736	1.1038
BT-20	Withaferin A	0.04	uM	LJP5	2	G18	72	hr	1097	3915	3769	1.0386	1.0544
BT-20	Withaferin A	0.04	uM	LJP5	3	G18	72	hr	1097	4381	3769	1.1622	1.2288
BT-20	Withaferin A	0.04	uM	LJP6	1	G18	72	hr	1097	4101	3769	1.0879	1.1240

|<
<<
Previous
Page 13 of 497
Next
>>
>
301 to 325 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)